GB0806074D0 - Novel estrogen receptor ligands - Google Patents
Novel estrogen receptor ligandsInfo
- Publication number
- GB0806074D0 GB0806074D0 GBGB0806074.1A GB0806074A GB0806074D0 GB 0806074 D0 GB0806074 D0 GB 0806074D0 GB 0806074 A GB0806074 A GB 0806074A GB 0806074 D0 GB0806074 D0 GB 0806074D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- estrogen receptor
- receptor ligands
- novel estrogen
- novel
- ligands
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/08—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0806074.1A GB0806074D0 (en) | 2008-04-03 | 2008-04-03 | Novel estrogen receptor ligands |
PCT/EP2009/053890 WO2009121910A1 (en) | 2008-04-03 | 2009-04-01 | Indene derivatives as estrogen receptor ligands |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0806074.1A GB0806074D0 (en) | 2008-04-03 | 2008-04-03 | Novel estrogen receptor ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0806074D0 true GB0806074D0 (en) | 2008-05-14 |
Family
ID=39433070
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0806074.1A Ceased GB0806074D0 (en) | 2008-04-03 | 2008-04-03 | Novel estrogen receptor ligands |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0806074D0 (en) |
WO (1) | WO2009121910A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201113538D0 (en) | 2011-08-04 | 2011-09-21 | Karobio Ab | Novel estrogen receptor ligands |
US9974776B2 (en) | 2013-12-05 | 2018-05-22 | Karo Pharma Ab | Estrogen receptor beta agonists for use in treating mesothelioma |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101790527A (en) * | 2006-07-20 | 2010-07-28 | 凯利普西斯公司 | The kinase whose benzothiophene inhibitors of RHO |
JP2010505898A (en) * | 2006-10-13 | 2010-02-25 | カロ バイオ アクチェブラーグ | 2-Phenylindene derivatives useful as estrogen receptor ligands |
-
2008
- 2008-04-03 GB GBGB0806074.1A patent/GB0806074D0/en not_active Ceased
-
2009
- 2009-04-01 WO PCT/EP2009/053890 patent/WO2009121910A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2009121910A1 (en) | 2009-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL208392A0 (en) | Novel estrogen receptor ligands | |
GB0917571D0 (en) | Novel estrogen receptor ligands | |
AU321286S (en) | Spout | |
IL209151A0 (en) | A lid-container for independent mixing | |
GB0821100D0 (en) | Antibodies | |
EP2219629A4 (en) | Novel compounds as cannabinoid receptor ligands | |
GB0820950D0 (en) | Funnel | |
IL207581A0 (en) | Anti-tyrp1 antibodies | |
GB0806656D0 (en) | Novel estrogen receptor ligands | |
IL200801A0 (en) | Pyrimidinyl-piperazines useful as d3/d2 receptor ligands | |
ZA201007976B (en) | Anti-pirb antibodies | |
GB0817221D0 (en) | Novel estrogen receptor ligands | |
DK2486010T3 (en) | Estrogen receptor ligands | |
GB0818356D0 (en) | Antibodies | |
GB0806657D0 (en) | Novel estrogen receptor ligands | |
GB0806074D0 (en) | Novel estrogen receptor ligands | |
HK1152039A1 (en) | Novel estrogen receptor ligands | |
GB0823367D0 (en) | Novel Estrogen Receptor Ligands | |
GB0806944D0 (en) | Novel estrogen receptor ligands | |
GB0803835D0 (en) | Novel estrogen receptor ligands | |
GB0707721D0 (en) | Novel estrogen receptor ligands | |
GB0917575D0 (en) | Novel estrogen receptor ligands | |
GB0917574D0 (en) | Novel estrogen receptor ligands | |
GB0620397D0 (en) | Novel estrogen receptor ligands | |
GB0714245D0 (en) | novel estrogwen receptor ligands |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |